Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism
- PMID: 12873915
- DOI: 10.1213/01.ANE.0000068983.18131.F0
Neurogenic and humoral vasoconstriction in acute pulmonary thromboembolism
Comment in
-
Pharmacologic therapy of pulmonary vasoconstriction in acute pulmonary embolism.Anesth Analg. 2004 Jan;98(1):273. doi: 10.1213/01.ANE.0000077707.55641.F9. Anesth Analg. 2004. PMID: 14693646 No abstract available.
References
-
- Wood K. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 2002; 121: 877–905.
-
- Soloff L, Rodman T. Acute pulmonary embolism. Am Heart J 1967; 74: 829–47.
-
- van Beek E, Kuijer P, Buller H, et al. The clinical course of patients with suspected pulmonary embolism. Arch Intern Med 1997; 157: 2593–8.
-
- Lualdi J, Goldhaber S. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 1995; 130: 1276–82.
-
- Capan L, Miller S. Monitoring for suspected pulmonary embolism. Anesthesiol Clin North America 2001; 19: 673–703.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
